RecruitingPhase 3NCT07654374
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Renton, WA · +73 more sites
Type 2 Diabetes clinical trials in Renton, WA
8 recruiting type 2 diabetes studies with a site in Renton, WA.
RecruitingNot applicableNCT07864168
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Sponsor: Medtronic MiniMed, Inc.
Renton, WA · Seattle, WA · +16 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Renton, WA · +22 more sites
RecruitingPhase 3NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Renton, WA · Seattle, WA · +61 more sites
RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Renton, WA · +26 more sites
RecruitingPhase not listedNCT07606066
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Sponsor: AstraZeneca
Renton, WA · +13 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Renton, WA · Seattle, WA · +31 more sites
RecruitingNot applicableNCT07518004
ROME GS System Study
Sponsor: Senseonics, Inc.
Renton, WA · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.